INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2024) III. Quarter |
(Jun 30 2024) II. Quarter |
|
|
|
Total Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Cost of Revenues |
- |
- |
- |
- |
- |
Gross
Profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
-0.01 |
- |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Fees and Commission |
0.01 |
- |
- |
- |
- |
Total operating costs including COS |
- |
- |
- |
- |
- |
Operating income/-loss
|
- |
- |
- |
- |
- |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
- |
-0.04 |
- |
- |
- |
Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax |
-0.19 |
- |
- |
- |
- |
Net Change In Unrealized Appreciation Depreciation On Investment |
-6.78 |
- |
- |
- |
- |
Unrealized Gain Loss On Investments |
-6.97 |
- |
- |
- |
- |
Total costs & expenses |
6.97 |
-0.04 |
0.00 |
0.00 |
0.00 |
Income /-loss before income taxes |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
EBIT |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
EBITD |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |
EBITDA |
-6.97 |
0.04 |
0.00 |
0.00 |
0.00 |